SCHEMBL3861786

SCHEMBL3861786

CCCCCCC=CCC(O)CC(=O)O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 1/20 0.68
▸ FFAR4 Q5NUL3 1/20 0.68
▸ NFKB1 P19838 1/20 0.60
▸ NFKB2 Q00653 1/20 0.60
▸ RELA Q04206 1/20 0.60
▸ FAAH O00519 2/20 0.58
▸ GPR84 Q9NQS5 4/20 0.58
▸ TERT O14746 3/20 0.58
▸ PTPN1 P18031 3/20 0.58
▸ PPARG P37231 3/20 0.58
▸ PPARD Q03181 3/20 0.58
▸ PPARA Q07869 3/20 0.58
▸ TOP1 P11387 3/20 0.58
▸ MAPT P10636 2/20 0.58
▸ BLM P54132 2/20 0.58
▸ HSD17B10 Q99714 2/20 0.58
▸ FABP4 P15090 2/20 0.58
▸ F7 P08709 2/20 0.58
▸ F3 P13726 2/20 0.58
▸ GMNN O75496 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL666849 1.00 FFAR1 (0.68) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL3861784 1.00 FFAR1 (0.68) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL5376194 1.00 FFAR1 (0.68) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL18464674 1.00 FFAR1 (0.68) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL4748084 1.00 FFAR1 (0.68) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL667529 1.00 FFAR1 (0.68) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL5376192 1.00 FFAR1 (0.68) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL4747867 1.00 FFAR1 (0.68) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL16338727 0.98 FFAR1 (0.65) FFAR1FFAR4NFKB1NFKB2RELA
SCHEMBL16338728 0.98 FFAR1 (0.65) FFAR1FFAR4NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026104020-A1 METHOD FOR RECOMBINANT PRODUCTION OF NOVEL GLYCOLIPIDS UNIVERSITÄT HOHENHEIM (DE) 2026-05-21 — — WO claimed
US-11787900-B2 Biodegradable sustainable polyesters MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-10-17 — — US claimed
US-20230151142-A1 BIODEGRADABLE SUSTAINABLE POLYESTERS MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2023-05-18 — — US claimed
WO-2023081515-A1 BIODEGRADABLE SUSTAINABLE POLYESTERS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-05-11 — — WO claimed
WO-2026104020-A1 METHOD FOR RECOMBINANT PRODUCTION OF NOVEL GLYCOLIPIDS UNIVERSITÄT HOHENHEIM (DE) 2026-05-21 — — WO disclosed
US-20250270567-A1 GENERATION OF ACYL AMINO ACIDS MODULAR GENETICS INC (US) 2025-08-28 — — US disclosed
US-20250188501-A1 SEMISYNTHETIC ROUTES TO ORGANIC COMPOUNDS AGAIN BIO APS (DK) 2025-06-12 — — US disclosed
US-12188068-B2 Semisynthetic routes to organic compounds GENOMATICA, INC. (US) 2025-01-07 — — US disclosed
US-12123004-B2 Generation of acyl amino acids MODULAR GENETICS, INC. (US) 2024-10-22 — — US disclosed
US-12031167-B2 Generation of acyl amino acids MODULAR GENETICS, INC. (US) 2024-07-09 — — US disclosed
US-11787900-B2 Biodegradable sustainable polyesters MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-10-17 — — US disclosed
US-20230151142-A1 BIODEGRADABLE SUSTAINABLE POLYESTERS MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2023-05-18 — — US disclosed
US-20060172400-A1 Bacterium for producing polyhydroxyalkanoate having polyhydroxyalkanoate depolymerase gene disrupted and method for producing polyhydroxyalkanoate using the same CANON KABUSHIKI KAISHA (JP) 2006-08-03 — — US disclosed
US-20060172398-A1 Isogenic strain line of bacterium for producing polyhydroxyalkanoate in which polyhydroxyalkanoate synthase gene is disrupted and method for producing polyhydroxyalkanoate using the same CANON KABUSHIKI KAISHA (JP) 2006-08-03 — — US disclosed
US-6514743-B2 Enzymatic polypeptide; for use in the generation of biodegradable plastic JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2003-02-04 — — US disclosed
US-6391611-B1 NUCLEOTIDE SEQUENCES CODING POLYPEPTIDE FOR USE GENERATION OF BIODEGRADABLE PLASTICS JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2002-05-21 — — US disclosed
EP-0575908-B1 Pseudomonas aeruginosa and its use in the preparation of L-rhamnose AVENTIS RES & TECH GMBH & CO (DE) 2000-03-15 — — EP disclosed
US-5658793-A SOURCE OF RHAMNOLIPIDS; HYDROLYSIS HOECHST AKTIENGESELLSCHAFT (DE) 1997-08-19 — — US disclosed
US-5501966-A Pseudomonas aeruginosa and its use in a process for the biotechnological preparation of L-rhamnose HOECHST AKTIENGESELLSCHAFT (DE) 1996-03-26 — — US disclosed
EP-0575908-A2 Pseudomonas aeruginosa and its use in the preparation of L-rhamnose HOECHST AKTIENGESELLSCHAFT (DE) 1993-12-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12031167-B2 Generation of acyl amino acids FADS1, FADS2, FAR1 FFAR1 21/4885FFAR4 87/4885NFKB1 2779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback